368 related articles for article (PubMed ID: 27295628)
41. Ligation of HLA Class I Molecules Induces YAP Activation through Src in Human Endothelial Cells.
Anwar T; Sinnett-Smith J; Jin YP; Reed EF; Rozengurt E
J Immunol; 2020 Oct; 205(7):1953-1961. PubMed ID: 32848033
[TBL] [Abstract][Full Text] [Related]
42. Hippo signalling governs cytosolic nucleic acid sensing through YAP/TAZ-mediated TBK1 blockade.
Zhang Q; Meng F; Chen S; Plouffe SW; Wu S; Liu S; Li X; Zhou R; Wang J; Zhao B; Liu J; Qin J; Zou J; Feng XH; Guan KL; Xu P
Nat Cell Biol; 2017 Apr; 19(4):362-374. PubMed ID: 28346439
[TBL] [Abstract][Full Text] [Related]
43. VGLL4 Protects against Oxidized-LDL-Induced Endothelial Cell Dysfunction and Inflammation by Activating Hippo-YAP/TEAD1 Signaling Pathway.
Xu K; Zhao H; Qiu X; Liu X; Zhao F; Zhao Y
Mediators Inflamm; 2020; 2020():8292173. PubMed ID: 33456372
[TBL] [Abstract][Full Text] [Related]
44. A functional interaction between Hippo-YAP signalling and FoxO1 mediates the oxidative stress response.
Shao D; Zhai P; Del Re DP; Sciarretta S; Yabuta N; Nojima H; Lim DS; Pan D; Sadoshima J
Nat Commun; 2014; 5():3315. PubMed ID: 24525530
[TBL] [Abstract][Full Text] [Related]
45. Shear-Induced CCN1 Promotes Atheroprone Endothelial Phenotypes and Atherosclerosis.
Hsu PL; Chen JS; Wang CY; Wu HL; Mo FE
Circulation; 2019 Jun; 139(25):2877-2891. PubMed ID: 30917686
[TBL] [Abstract][Full Text] [Related]
46. Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ.
Yi J; Lu L; Yanger K; Wang W; Sohn BH; Stanger BZ; Zhang M; Martin JF; Ajani JA; Chen J; Lee JS; Song S; Johnson RL
Hepatology; 2016 Nov; 64(5):1757-1772. PubMed ID: 27531557
[TBL] [Abstract][Full Text] [Related]
47. An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.
Park GS; Oh H; Kim M; Kim T; Johnson RL; Irvine KD; Lim DS
Oncotarget; 2016 Apr; 7(17):24063-75. PubMed ID: 27006470
[TBL] [Abstract][Full Text] [Related]
48. Actin cytoskeleton regulates Hippo signaling.
Reddy P; Deguchi M; Cheng Y; Hsueh AJ
PLoS One; 2013; 8(9):e73763. PubMed ID: 24040060
[TBL] [Abstract][Full Text] [Related]
49. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.
Kemppainen K; Wentus N; Lassila T; Laiho A; Törnquist K
Cell Signal; 2016 Dec; 28(12):1894-1903. PubMed ID: 27634386
[TBL] [Abstract][Full Text] [Related]
50. Macrophage K63-Linked Ubiquitination of YAP Promotes Its Nuclear Localization and Exacerbates Atherosclerosis.
Liu M; Yan M; Lv H; Wang B; Lv X; Zhang H; Xiang S; Du J; Liu T; Tian Y; Zhang X; Zhou F; Cheng T; Zhu Y; Jiang H; Cao Y; Ai D
Cell Rep; 2020 Aug; 32(5):107990. PubMed ID: 32755583
[TBL] [Abstract][Full Text] [Related]
51. Hippo signaling pathway is altered in Duchenne muscular dystrophy.
Vita GL; Polito F; Oteri R; Arrigo R; Ciranni AM; Musumeci O; Messina S; Rodolico C; Di Giorgio RM; Vita G; Aguennouz M
PLoS One; 2018; 13(10):e0205514. PubMed ID: 30304034
[TBL] [Abstract][Full Text] [Related]
52. Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism.
Yuan L; Mao Y; Luo W; Wu W; Xu H; Wang XL; Shen YH
J Biol Chem; 2017 Sep; 292(36):15002-15015. PubMed ID: 28698384
[TBL] [Abstract][Full Text] [Related]
53. Cell growth density modulates cancer cell vascular invasion via Hippo pathway activity and CXCR2 signaling.
Sharif GM; Schmidt MO; Yi C; Hu Z; Haddad BR; Glasgow E; Riegel AT; Wellstein A
Oncogene; 2015 Nov; 34(48):5879-89. PubMed ID: 25772246
[TBL] [Abstract][Full Text] [Related]
54. The Characteristic of S100A7 Induction by the Hippo-YAP Pathway in Cervical and Glossopharyngeal Squamous Cell Carcinoma.
Kong F; Li Y; Hu E; Wang R; Wang J; Liu J; Zhang J; He D; Xiao X
PLoS One; 2016; 11(12):e0167080. PubMed ID: 27907036
[TBL] [Abstract][Full Text] [Related]
55. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
56. Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP.
Yang Y; Ma Q; Li Z; Wang H; Zhang C; Liu Y; Li B; Wang Y; Cui Q; Xue F; Ai D; Zhu Y; He J
Br J Pharmacol; 2021 Apr; 178(7):1524-1540. PubMed ID: 33474722
[TBL] [Abstract][Full Text] [Related]
57. Neddylation mediates ventricular chamber maturation through repression of Hippo signaling.
Zou J; Ma W; Li J; Littlejohn R; Zhou H; Kim IM; Fulton DJR; Chen W; Weintraub NL; Zhou J; Su H
Proc Natl Acad Sci U S A; 2018 Apr; 115(17):E4101-E4110. PubMed ID: 29632206
[TBL] [Abstract][Full Text] [Related]
58. RARγ Downregulation Contributes to Colorectal Tumorigenesis and Metastasis by Derepressing the Hippo-Yap Pathway.
Guo PD; Lu XX; Gan WJ; Li XM; He XS; Zhang S; Ji QH; Zhou F; Cao Y; Wang JR; Li JM; Wu H
Cancer Res; 2016 Jul; 76(13):3813-25. PubMed ID: 27325643
[TBL] [Abstract][Full Text] [Related]
59. Regulation of the Hippo-YAP Pathway by Glucose Sensor O-GlcNAcylation.
Peng C; Zhu Y; Zhang W; Liao Q; Chen Y; Zhao X; Guo Q; Shen P; Zhen B; Qian X; Yang D; Zhang JS; Xiao D; Qin W; Pei H
Mol Cell; 2017 Nov; 68(3):591-604.e5. PubMed ID: 29100056
[TBL] [Abstract][Full Text] [Related]
60. YAP/TAZ-CDC42 signaling regulates vascular tip cell migration.
Sakabe M; Fan J; Odaka Y; Liu N; Hassan A; Duan X; Stump P; Byerly L; Donaldson M; Hao J; Fruttiger M; Lu QR; Zheng Y; Lang RA; Xin M
Proc Natl Acad Sci U S A; 2017 Oct; 114(41):10918-10923. PubMed ID: 28973878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]